103 related articles for article (PubMed ID: 1706762)
1. Effect of pyrrolidone derivatives on lipid membrane and protein conformation as transdermal penetration enhancer.
Sasaki H; Kishikawa M; Nakamura J; Shibasaki J
J Pharmacobiodyn; 1990 Aug; 13(8):468-74. PubMed ID: 1706762
[TBL] [Abstract][Full Text] [Related]
2. Enhancing effect of pyrrolidone derivatives on the transdermal penetration of sulfaguanidine, aminopyrine and Sudan III.
Sasaki H; Kojima M; Nakamura J; Shibasaki J
J Pharmacobiodyn; 1990 Mar; 13(3):200-5. PubMed ID: 2374089
[TBL] [Abstract][Full Text] [Related]
3. Enhancing effect of pyrrolidone derivatives on transdermal penetration of 5-fluorouracil, triamcinolone acetonide, indomethacin, and flurbiprofen.
Sasaki H; Kojima M; Mori Y; Nakamura J; Shibasaki J
J Pharm Sci; 1991 Jun; 80(6):533-8. PubMed ID: 1941542
[TBL] [Abstract][Full Text] [Related]
4. Acute toxicity and skin irritation of pyrrolidone derivatives as transdermal penetration enhancer.
Sasaki H; Kojima M; Nakamura J; Shibasaki J
Chem Pharm Bull (Tokyo); 1990 Aug; 38(8):2308-10. PubMed ID: 2149084
[TBL] [Abstract][Full Text] [Related]
5. Enhancing effect of pyrrolidone derivatives on transdermal penetration of phenolsulfonphthalein and indomethacin from aqueous vehicle.
Sasaki H; Kojima M; Nakamura J; Shibasaki J
Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):797-9. PubMed ID: 2347025
[TBL] [Abstract][Full Text] [Related]
6. Enhancing effect of combining two pyrrolidone vehicles on transdermal drug delivery.
Sasaki H; Kojima M; Nakamura J; Shibasaki J
J Pharm Pharmacol; 1990 Mar; 42(3):196-9. PubMed ID: 1974617
[TBL] [Abstract][Full Text] [Related]
7. Preparation of alkyl-substituted pyrrolidone derivatives and their evaluation as transdermal penetration enhancers.
Aoyagi T; Yamamura M; Suzuki N; Matsui K; Nagase Y
Drug Des Discov; 1991 Nov; 8(1):37-46. PubMed ID: 1810410
[TBL] [Abstract][Full Text] [Related]
8. Enhancing effect of N-dodecyl-2-pyrrolidone on the percutaneous absorption of 5-fluorouracil derivatives.
Sato S; Hirotani Y; Ogura N; Sasaki E; Kitagawa S
Chem Pharm Bull (Tokyo); 1998 May; 46(5):831-6. PubMed ID: 9621418
[TBL] [Abstract][Full Text] [Related]
9. Combination effect of penetration enhancers and propylene glycol on in vitro transdermal absorption of insulin.
Príborský J; Takayama K; Nagai T; Waitzová D; Elis J
Drug Des Deliv; 1987 Dec; 2(2):91-7. PubMed ID: 3334547
[TBL] [Abstract][Full Text] [Related]
10. Enhancing effect of absorption promoters on percutaneous absorption of a model dye (6-carboxyfluorescein) as a poorly absorbable drug. III. Histological study after addition of various absorption promoters in rats.
Ohshima T; Yoshikawa H; Takada K; Muranishi S
J Pharmacobiodyn; 1986 Mar; 9(3):223-8. PubMed ID: 2425072
[TBL] [Abstract][Full Text] [Related]
11. Effect of penetration enhancers on the transdermal delivery of bupranolol through rat skin.
Babu RJ; Pandit JK
Drug Deliv; 2005; 12(3):165-9. PubMed ID: 16025846
[TBL] [Abstract][Full Text] [Related]
12. Study on the mechanisms of chitosan and its derivatives used as transdermal penetration enhancers.
He W; Guo X; Xiao L; Feng M
Int J Pharm; 2009 Dec; 382(1-2):234-43. PubMed ID: 19686826
[TBL] [Abstract][Full Text] [Related]
13. Keratinized epithelial transport of beta-blocking agents. III. Evaluation of enhancing effect on percutaneous absorption using model lipid liposomes.
Kai T; Nakazono M; Kurosaki Y; Nakayama T; Kimura T
Biol Pharm Bull; 1993 Aug; 16(8):801-5. PubMed ID: 8106078
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of in-vitro percutaneous absorption across human skin and in animal models.
Príborský J; Mühlbachová E
J Pharm Pharmacol; 1990 Jul; 42(7):468-72. PubMed ID: 1980285
[TBL] [Abstract][Full Text] [Related]
15. Skin penetration and deposition of carboxyfluorescein and temoporfin from different lipid vesicular systems: In vitro study with finite and infinite dosage application.
Chen M; Liu X; Fahr A
Int J Pharm; 2011 Apr; 408(1-2):223-34. PubMed ID: 21316430
[TBL] [Abstract][Full Text] [Related]
16. Preparation, characterization and pharmacological evaluation of tolterodine hydrogels for the treatment of overactive bladder.
Sun F; Sui C; Zhou Y; Liu X; Shi Y; Wu Y; Li Y
Int J Pharm; 2013 Sep; 454(1):532-8. PubMed ID: 23891744
[TBL] [Abstract][Full Text] [Related]
17. Role of n-methyl pyrrolidone in the enhancement of aqueous phase transdermal transport.
Lee PJ; Langer R; Shastri VP
J Pharm Sci; 2005 Apr; 94(4):912-7. PubMed ID: 15736187
[TBL] [Abstract][Full Text] [Related]
18. Transcutaneous drug delivery by liposomes using fractional laser technology.
Fujimoto T; Wang J; Baba K; Oki Y; Hiruta Y; Ito M; Ito S; Kanazawa H
Lasers Surg Med; 2017 Jul; 49(5):525-532. PubMed ID: 27990655
[TBL] [Abstract][Full Text] [Related]
19. Transdermal permeation of drugs with differing lipophilicity: Effect of penetration enhancer camphor.
Xie F; Chai JK; Hu Q; Yu YH; Ma L; Liu LY; Zhang XL; Li BL; Zhang DH
Int J Pharm; 2016 Jun; 507(1-2):90-101. PubMed ID: 27154251
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of action of different concentrations of ethanol in water on ordered structures of intercellular lipids and soft keratin in the stratum corneum.
Horita D; Hatta I; Yoshimoto M; Kitao Y; Todo H; Sugibayashi K
Biochim Biophys Acta; 2015 May; 1848(5):1196-202. PubMed ID: 25698224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
